RT-PGR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone

Toxicological Sciences

Volumn 47, Issue 1, 1999, Pages 76-85

  Abbott, B D ^a   Schmid, J E ^a   Brown, J G ^a,b   Wood, C R ^a   White, R D ^a,c   Buckalew, A R ^a   Held, G A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Santa Cruz Biotechnology   (United States)

Author keywords

Ah receptor (AhR); AhR nuclear translocator (ARNT); CYP1A1; Dioxin (Ah); Glucocorticoid receptor; Hydrocortisone; Palate; Quantitative RT PCR

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARRIER PROTEIN; ETHOXYRESORUFIN DEETHYLASE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; ARNT PROTEIN, MOUSE; CYTOCHROME P450 1A1; DNA BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1BETA; TERATOGENIC AGENT; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; PALATE; POLLUTANT; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; BLOTTING, NORTHERN; CYTOCHROME P-450 CYP1A1; DNA-BINDING PROTEINS; ENVIRONMENTAL POLLUTANTS; FEMALE; HYDROCORTISONE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PALATE; PREGNANCY; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TERATOGENS; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTORS;

EID: 0032589068     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/47.1.76     Document Type: Article

References (52)

1. Abbott, B. D. (1995), A review of the interaction between TCDD and glucocorticoids in the embryonic palate. Toxicology 105, 365-373.
2. Abbott, B. D. (1997). Developmental toxicity of dioxin: Searching for the cellular and molecular basis of morphological responses. In Handbook of Experimental Pharmacology 124/II: Drug Toxicity in Embryonic Development II. (R. J. Kavlock and G. P. Dastor, Eds.), Section III: Pathogenesis and mechanisms of drug toxicity in development, pp. 407-433. Springer-Verlag New York.
3. Abbott, B. D., and Birnbaum, L. S. (1989a). TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol. Appl. Pharmacol. 99, 276-286.
4. Abbott, B. D., and Birnbaum, L. S. (1989b). Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 99, 287-301.
5. Abbott, B. D., and Birnbaum, L. S. (1990). TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106, 418-432.
6. Abbott, B. D., Birnbaum, L. S., and Diliberto, J. J. (1996). Rapid distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to embryonic tissues in C57BL/6N mice and correlation with palatal uptake in vitro. Toxicol. Appl. Pharmacol. 141, 256-263.
7. Abbott B. D., Birnbaum L. S., and Perdew, G. H. (1995). Developmental expression of two members of a new class of transcriptional factors. Part I: Expression of Ah receptor in the C57BL/6N mouse embryo. Dev. Dyn. 204, 133-143.
8. Abbott, B. D., and Buckalew, A. R. (1992). Embryonic palatal responses to teratogens in serum-free organ culture. Teratology 45, 369-382.
9. Abbott, B. D., Diliberto, J. J., and Birnbaum, L. S. (1989). TCDD alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100, 119-131.
10. Abbott, B. D., Harris, M. W., and Birnbaum, L. S. (1992). Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into the synergistic interaction occurring in embryonic palates. Teratology 45, 35-53.
11. Abbott, B. D., McNabb, F. M. A., and Lau, C. (1994c). Glucocorticoid receptor expression during the development of the embryonic mouse secondary palate. J. Craniofac. Genet. Dev. Biol. 14, 87-96.
12. Abbott B. D., Perdew G. H., and Birnbaum, L. S. (1994a). Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126, 16-25.
13. Abbott, B. D., Perdew, G. H., Buckalew, A. R., and Birnbaum, L. S. (1994b). Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by TCDD and hydrocortisone. Toxicol. Appl. Pharmacol. 128, 138-150.
14. Abbott B. D., and Probst, M. R. (1995). Developmental expression of two members of a new class of transcriptional factors. Part II: Expression of Ah receptor nuclear translocator (ARNT) in the C57BL/6N mouse embryo. Dev. Dyn. 204, 144-155.
15. Baxter H., and Fraser, F. C. (1950). Production of congenital defects in the offspring of female mice treated with cortisone. McGill Med. J. 19, 245-249.
16. Biddle, F. G., and Fraser, F. C. (1976). Genetics of cortisone-induced cleft palate in the mouse-embryonic and maternal effects. Genetics 84, 743-754.
17. Birnbaum, L. S., Harris, M. W., Miller, C. P., Pratt, R. M., and Lamb, J. C. (1986). Synergistic interaction of 2,3,7,8-tetracholordibenzo-p-dioxin and hydrocortisone in the induction of cleft palate in mice. Teratology 33, 29-35.
18. Birnbaum, L. S. (1995). The developmental effects of dioxins. Environ. Health. Persp. 103(Suppl. 7), 89-95.
19. Celander, M., Weisbrod, R., and Stegeman, J. J. (1997). Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture. Biochem. Biophys. Res. Commun. 232, 749-753.
20. Couture, L. A., Abbott, B.D., Birnbaum, L. S. (1990a) A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 42, 619-627.
21. Danielsen, M., Northrop, J. P., and Ringold, G. M. (1986). The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J. 5, 2513-2522.
22. Davis, L. G., Dibner, M. D., and Battey, J. F. (1986). Basic Methods in Molecular Biology. Elsevier, New York.
23. Goldstein, J. A., Lin, F. H., Stohs, S. J., Graham, M., Clarke, G., Birnbaum, L., and Lucier, G. (1990). The effects of TCDD on receptors for epidermal growth factor, glucocorticoid, and estrogen in Ah-responsive and -nonresponsive congenic mice and the effects of TCDD on estradiol metabolism in a liver tumor promotion model in female rats. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, pp. 187-202. Alan R. Liss, New York.
24. 3-450. Gene 29, 281-292.
25. Held, G., and Abbott, B. D. (1999). Palatal dysmorphogenesis: quantitative RT-PCR. In: Methods in Molecular Biology, Developmental Biology Protocols, (R. S. Tuan and C. W. Lo, Eds.), Chap. 64. Humana Press, Totowa, NJ.
26. Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
27. Hollander, M., and Wolfe, D. A. (1973). Nonparametric Statistical Methods, pp. 83-92. John Wiley and Sons, New York.
28. Holmes, J. L., and Pollenz, R. S. (1997). Determination of Aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: Development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Molec. Pharmacol. 52, 202-211.
29. 3-450 cDNA nucleotide and amino acid sequences. J. Biol. Chem. 259, 10705-10713.
30. Kozak, K. R., Abbott, B., and Hankinson, O. (1997). ARNT-deficient mice and placental differentiation. Dev. Biol. 191, 297-305.
31. Lau, E. C., Li, Z.-Q., Santos, V., and Slavkin, H. C. (1993). Messenger RNA phenotyping for semi-quantitative comparison of glucocorticoid receptor transcript levels in the developing embryonic mouse palate. J. Steroid Biochem. Molec. Biol. 46, 751-758.
32. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. (1997). Abnormal angiogenesis and response to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407.
33. Muller, M., and Renkawitz, R. (1991). The glucocorticoid receptor. Biochim. Biophys. Acta 1088, 171-182.
34. Neubert, D., Zens, P., Rothenwallner, A., and Merker, H. J. (1973). A survey of the embryotoxic effects of TCDD in mammalian species. Environ. Health Perspect. 5, 67-79.
35. Peterka, M., and Jelinek, R., (1978). Differences in size of thepalatal processes in mouse embryos with cleft palate induced in two critical periods. Cleft Palate J. 15, 13-19.
36. Pollenz, R. S., Santosteffano, M. J., Klett, E., Richardson, V. M., Necela, B., and Birnbaum, L. S. (1998). Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus, and lung. Toxicol. Sci. 42, 117-128
37. Pratt, R. M., Dencker, L., and Diewert, V. M. (1984). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratogen. Carcinogen. Mutagen. 4, 427-436.
38. Randles, R. H., and Wolfe, D. A. (1979). Introduction to the Theory of Nonparametric Statistics, pp. 344-355. John Wiley and Sons, New York.
39. Reisz-Porszasz, S., Probst, M. R., Fukunaga, B. N., and Hankinson, O. (1994). Identification of functional domains of the arylhydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell Biol. 14, 6075-6086.
40. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (ARNT) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
41. Rowlands, J. C. and Gustafsson, J.-Å. (1997). Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol. 27, 109-134.
42. SAS Institute. (1989). SAS/STAT User's Guide, Version 6, 4th ed., Vol. 2, SAS Institute, Cary, NC.
43. SAS Institute. (1990). SAS Language: reference, Version 6, 1st ed., SAS Institute, Cary, NC.
44. SAS Institute. (1992). SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07. SAS Institute, Cary. NC.
45. Schmidt, J. V., and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
46. Schmidt, J. V., Carver, L. A., and Bradfield, C. A. (1993). Molecular characterization of the murine Ahr gene: Organization, promoter analysis, and chromosomal assignment. J. Biol. Chem. 268, 22203-22209.
47. Sunahara, G. I., Lucier, G. W., McCoy, Z., Bresnick, E. H., Sanchez, E. R., and Nelson, K. G. (1989). Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decreases in dexamethasone binding torat hepatic cytosolic glucocorticoid receptor. Molec. Pharmacol. 36, 239-247.
48. Vanden Heuvel, J. P., Clark, G. C., Kohn, M. C., Tritscher, A. M., Greenlee, W. F., Lucier, G. W., and Bell, D. A. (1994). Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54, 62-68.
49. Vanden Heuvel, J. P., Tyson, F. L., and Bell, D. A. (1993). Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. BioTechniques 14, 395-398.
50. Wenger, R. H., and Gassmann, M. (1997). Oxygen(s) and the hypoxia-inducible factor-1. Biolog. Chem. 378, 609-616.
51. Whitlock, J. P., Jr., Okino, S. T., Dong, L., Ko, H. P., Clarke-Katzenberg, R., Ma, Q., and Li, H. (1996). Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10, 809-818.
52. Zimmerman, E. F. (1997). Palate. In: Handbook of Experimental Pharmacology 124/I: Drug Toxicity in Embryonic Development 1. (R. J. Kavlock, G. P. Daston, Eds.) pp. 183-208. Springer-Verlag, New York.